| JYSB2000089 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-03-24 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-03-30 | view |
| JYSB2000135 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-04-26 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-07-16 | view |
| JYSB2000136 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-04-28 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Certificate Issued | 2020-09-04 | view |
| JYSB2000280 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-06-18 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-06-22 | view |
| JYSB2000420 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-08-27 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2020-08-26 | view |
| JYSB2000513 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2020-10-13 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | Filed | 2020-10-21 | view |
| JYSB2100002 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-01-07 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-01-06 | view |
| JYSB2100003 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-01-07 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-01-06 | view |
| JYSB2100074 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-03-12 | Janssen-Cilag International NV | Janssen-Cilag International NV;Cilag AG | In Review | 2021-03-12 | view |
| JYSB2101024 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-05-14 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2101133 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-09-13 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JXSL2101112 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-29 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2101113 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-29 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2101188 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-12-09 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2101189 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2021-12-09 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JXSL2200033 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-03-22 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2200074 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-06-09 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSL2200075 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-06-09 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2200148 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JYSB2200149 | 古塞奇尤单抗注射液 | guselkumab | Injection | Biological Products | Supplementary Application | 2022-08-30 | | Cilag AG;Janssen Research & Development LLC | | | view |
